"PPD is a clinical research facility located in Austin, TX, recruiting generally healthy volunteers 18 and older to participate in clinical trials, and financially compensating them for participation. Some of these studies are outpatient or even at-home trials, while others require a stay at our facility. To learn more or to see if you qualify for an Austin research study, call PPD today for a confidential conversation."

During the past decade, PPD Development, LP conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 8 clinical trials were completed, i.e. on average, 19.5% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 6 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "PPD Development, LP" #1 sponsor was "Bristol-Myers Squibb" with 21 trials, followed by "AstraZeneca" with 11 trials sponsored, "United Therapeutics" with 7 trials sponsored, "Kowa Research Institute, Inc." with 4 trials sponsored and "Agios Pharmaceuticals, Inc." with 4 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "PPD Development, LP" #1 collaborator was "Bristol-Myers Squibb" with 5 trials as a collaborator, "PPD" with 3 trials as a collaborator, "ARMO BioSciences" with 2 trials as a collaborator and "Ionis Pharmaceuticals, Inc." with 2 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "PPD Development, LP" are "Healthy Volunteers" (13 trials), "Healthy" (11 trials), "Type 2 Diabetes Mellitus" (7 trials), "Pulmonary Arterial Hypertension" (5 trials) and "Rheumatoid Arthritis" (5 trials). Many other conditions were trialed in "PPD Development, LP" in a lesser frequency.

Most popular intervention types in "PPD Development, LP" are "Drug" (67 trials), "Biological" (6 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Dapagliflozin" (4 trials), "Midazolam" (4 trials), "Treprostinil diethanolamine" (4 trials) and "Itraconazole" (3 trials). Other intervention names were less common.

The vast majority of trials in "PPD Development, LP" are 71 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "PPD Development, LP". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 67 completed trials in PPD Development, LP, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in PPD Development, LP, 71 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

PPD Development, LP has several departments that took part in Clinical trials: "Ppd Development" - 4 trials, "PPD Development, LP" - 4 trials